Results 191 to 200 of about 29,574,253 (245)
volume 10, no. 1 (Winter 2006) [PDF]
Office of University Advancement, Bryant University
core +1 more source
Correction: Aboubakr et al. Antioxidant and Anti-Inflammatory Potential of Thymoquinone and Lycopene Mitigate the Chlorpyrifos-Induced Toxic Neuropathy. <i>Pharmaceuticals</i> 2021, <i>14</i>, 940. [PDF]
Aboubakr M+13 more
europepmc +1 more source
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma+9 more
wiley +1 more source
volume 14, no. 3 (Winter 2010) [PDF]
Office of University Advancement, Bryant University
core +1 more source
Hepatic Phenotype in NBAS-Associated Disease: Clinical Course, Prognostic Factors and Outcome in 230 Patients. [PDF]
Peters B+32 more
europepmc +1 more source
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu+12 more
wiley +1 more source
volume 14, no. 2 (Summer 2009) [PDF]
Office of University Advancement, Bryant University
core +1 more source
Correction: Utilizing actinobacteria for glyphosate biodegradation: innovative solutions for sustainable agricultural soil remediation. [PDF]
Rebai H+7 more
europepmc +1 more source
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci+6 more
wiley +1 more source
volume 25, no. 1 (Spring 2018) [PDF]
Office of University Advancement, Bryant University
core +1 more source